Abstract
With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy–induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.
Original language | English |
---|---|
Pages (from-to) | 1199-1213 |
Number of pages | 15 |
Journal | Journal of the American Academy of Dermatology |
Volume | 80 |
Issue number | 5 |
Early online date | 14 Apr 2018 |
DOIs | |
Publication status | Published - 1 May 2019 |
Keywords
- alopecia
- cancer survivors
- cancer therapy
- endocrine therapy
- hirsutism
- hypertrichosis
- persistent alopecia
- persistent chemotherapy-induced alopecia
- persistent radiotherapy-induced alopecia
- quality of life
- therapeutic transplants